Search Within

Carol A Aghajanian

Formats
  1. Journal Article (320)
  2. Meeting Abstract (284)
  3. Review (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (609)
  2. GDMT, Medicine (609)
  3. Gynecologic Medicine Service (609)
  4. Gynecology Disease Management Team (609)
  5. Solid Tumor Oncology Division (609)
  6. Surgery (226)

More Groups

People
  1. Paul Sabbatini (125)
  2. Nadeem Abu-Rustum (123)
  3. Alexia Iasonos (115)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (18)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (198)
  2. Journal of Clinical Oncology (149)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier Inc. (216)
  2. American Society of Clinical Oncology (155)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Wiley Blackwell (17)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial Efficacy and Safety Results from ENGOT-Ov60/GOG-3052/ramp 201: A phase 2 study of avutometinib (vs-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Ring, K. L.; Van Niewenhuysen, E.; Fabbro, M.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Santin, A. D.; Clamp, A. R.; Moore, K. N.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Updated response data and analysis of progression free survival by mechanism of mismatch repair loss in endometrial cancer (EC) patients (pts) treated with pembrolizumab plus carboplatin/ paclitaxel (CP) as compared to CP plus placebo (PBO) in the NRG GY018 trial
    Meeting Abstract

    Eskander, R. N.; Sill, M.; Miller, A.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M. S.; Canturia, G.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Modern associations of uterine carcinomas with prior exposure to tamoxifen
    Meeting Abstract

    Rios-Doria, E.; Hodgson, A.; Aviki, E.; Zivanovic, O.; Friedman, C.; Aghajanian, C.; Makker, V.; Liu, Y.; Zamarin, D.; Leitao, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
    Meeting Abstract

    Praiss, A.; Park, K.; Zhou, Q.; White, C.; Iasonos, A.; Zivanovic, O.; Abu-Rustum, N.; Weigelt, B.; Aghajanian, C.; Grisham, R.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study
    Meeting Abstract

    Eskander, R.; Sill, M.; Beffa, L.; Moore, R.; Hope, J.; Musa, F.; Mannel, R.; Shahin, M.; Cantuaria, G.; Girda, E.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study
    Meeting Abstract

    Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Transforming ovarian cancer care by targeting minimal residual disease
    Editorial

    Jazaeri, A. A.; Grisham, R.; Knisely, A.; Spranger, S.; Zamarin, D.; Hillman, R. T.; Lawson, B. C.; Burns, K. H.; Lee, S.; Westin, S. N.; more...
    Med (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save